Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT06428201
Other study ID # MSRSW/Batch-Fall22/711
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date September 1, 2023
Est. completion date September 1, 2024

Study information

Verified date May 2024
Source Superior University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

"This study investigates the feasibility of tele-rehabilitation combined with targeted training for cognitive enhancement in individuals with Multiple Sclerosis (MS). Multiple sclerosis (MS) is a chronic illness that affects the central nervous system, often resulting in cognitive impairments that significantly impact quality of life. Tele-restoration provides an accessible and effective method for delivering therapeutic interventions, particularly beneficial for those with mobility limitations.


Description:

The study was a randomized controlled trial with multiple sclerosis patients divided into two groups: one receiving tele-rehabilitation-based task-specific training and the other receiving conventional care. The mediation group participated in structured cognitive training sessions conducted using a tele-rehabilitation platform, focusing on tasks designed to enhance memory, attention, and executive functions. Psychological assessments were conducted during the mediation period to measure improvements.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 52
Est. completion date September 1, 2024
Est. primary completion date April 1, 2024
Accepts healthy volunteers No
Gender All
Age group 20 Years to 45 Years
Eligibility Inclusion Criteria: - Individuals with a diagnosis of MS confirmed by a neurologist. - Between 18 and 65 years of age. - Presence of psychosis confirmed by standardized psychometric testing. - A stable treatment environment that allows intervention. - Internet access with camera and computer/tablet. - Ability to understand and follow course directions. - Willingness to give informed consent. Exclusion Criteria: - Severe psychiatric co-morbidities affecting cognitive function. - Concurrent intervention with other psychological rehabilitation programs. - Lack of availability or use of technology necessary for tele-rehabilitation. - Further research interventions. - Unstable medical condition

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Control Group
The control group receives standard care, which includes routine medical management and general physical rehabilitation exercises. This involves regular consultations with healthcare providers and exercises aimed at maintaining mobility and physical function. The control group also follows a schedule of three 45-minute sessions per week for 12 weeks, ensuring a consistent comparison with the experimental group.
Combination Product:
Experimental Group
The experimental intervention involves tele-rehabilitation-based task-specific training to enhance cognitive functions in multiple sclerosis (MS) patients. This program includes cognitive exercises targeting memory, attention, executive function, and processing speed, conducted remotely via a tele-rehabilitation platform. Patients participate in three 45-minute sessions per week for 12 weeks. Each session is guided by a trained therapist, ensuring personalized support and real-time feedback.

Locations

Country Name City State
Pakistan District Head Quarters Hospital Narowal, Circular Road, Near Jassar Bypass, Narowal Location: Khalid Eye & Medical Care Block C Commercial Area, Jubilee Town, Lahore Lahore Punjab

Sponsors (1)

Lead Sponsor Collaborator
Superior University

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Montreal Cognitive Assessment (MoCA) scale The MoCA scale is a comprehensive tool designed to evaluate various cognitive domains, including attention and concentration, executive functions, memory, language, visuospatial skills, conceptual thinking, calculations, and orientation. It provides a detailed assessment of cognitive performance, making it an ideal measure for tracking cognitive improvements in MS patients participating in the tele-rehabilitation and task-specific training programs. 12 Months
See also
  Status Clinical Trial Phase
Recruiting NCT03540485 - Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis Phase 1/Phase 2
Recruiting NCT05912595 - EXOPULSE Mollii Suit, Spasticity, Muscular Oxygenation & Multiple Sclerosis (ENNOX 2) N/A
Recruiting NCT05857280 - EXOPULSE Mollii Suit, Motor Function & Multiple Sclerosis (EXOSEP 2) N/A
Completed NCT06220409 - Gut Microbiota Composition, Cognitive Function, and Physical Fitness in Multiple Sclerosis Patients N/A
Recruiting NCT03600779 - Application of ihMT MRI in Multiple Sclerosis N/A
Recruiting NCT03999034 - XO as a Screening Test of Cognitive Impairment in Multiple Sclerosis N/A
Not yet recruiting NCT06112639 - The DANCEREX Proof-of-Concept Study for Chronic Neurological Disorders N/A
Completed NCT06061939 - Effects of Blood Flow Restriction Training on Middle-aged People With Multiple Sclerosis. N/A
Terminated NCT03983720 - Can Fatigability Neuromuscular Explain Chronic Fatigue in People With Multiple Sclerosis? Phase 2
Withdrawn NCT04674163 - Expression Profile of ERK5 and PKM2 Kinases in Neuroinflammatory Diseases. N/A
Not yet recruiting NCT03751306 - Aerobic Exercise and Transcranial Low Laser Therapy in Patients With Central Nervous System Injury N/A
Active, not recruiting NCT03508089 - Exploration of Microcirculatory Alteration and Endothelial Dysfunction by Adaptive Optics in Multiple Sclerosis N/A
Recruiting NCT03900221 - French Registry for Monitoring Pregnancies for Multiple Sclerosis